Phong Phu Pharmaceutical Joint Stock Company (HNX: PPP)
Health Care · Pharmaceuticals · VN
₫18,500.00
+0.54% today · -12.3% 1Y
Phong Phu Pharmaceutical Joint Stock Company (HNX: PPP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.22M.
Over the last twelve months the share price has lost 12.3%, trading between 17.70K and 22.70K.
Tweenvest scores Phong Phu Pharmaceutical Joint Stock Company across four factors: quality 69/100, value 74/100, growth 43/100, dividend 90/100. Its strongest factor is dividend.
PPP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.22M
- Revenue (TTM)
- $5.83M
- P/E
- 5.85
- EPS
- 3,163.55
- Dividend yield
- 8.11%
- Beta (5Y)
- -0.06
- 52-week high
- ₫22,700.00
- 52-week low
- ₫17,700.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.80M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,245.00 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.54 | -0.55% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.00 | +0.23% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.04 | +0.25% |
Figures last refreshed Aug 18, 2026.